Prescription Drug Price Relief Act: Ending Costly Monopolies
This act aims to lower prescription drug prices in the U.S. If a drug's price is higher than in other countries, the government can revoke the manufacturer's exclusive rights. This paves the way for cheaper alternatives, potentially reducing medication costs for many citizens.
Key points
The government will review brand-name drug prices to determine if they are excessive compared to prices in Canada, the UK, Germany, France, and Japan.
If a drug's price is deemed excessive, the government can allow other companies to produce and sell cheaper versions of that drug.
Drug manufacturers will be required to report detailed data on prices, research costs, and marketing, with penalties for non-compliance or false information.
A public database will be created to provide information on drug prices and excessive price determinations, increasing transparency.
Expired
Citizen Poll